CID-16020046

CID-16020046 is a chemical compound that has been identified as a potent and selective inhibitor of the enzyme G9a and GLP, which are both involved in methylation processes. This compound has been studied for its potential use in the treatment of various diseases, including cancer and neurodegenerative diseases.

Chemical Properties

CID-16020046 is a small molecule with a molecular weight of 446.9 g/mol. It has a complex chemical structure, which includes a benzene ring and several nitrogen and oxygen atoms. The compound is typically presented as a white to off-white powder.

Biological Activity

CID-16020046 has been shown to inhibit the activity of G9a and GLP, two enzymes that are involved in the methylation of histone proteins. This methylation process is important for the regulation of gene expression, and abnormalities in this process have been linked to a variety of diseases.

In particular, overactivity of G9a and GLP has been associated with certain types of cancer, including lung cancer and leukemia. By inhibiting these enzymes, CID-16020046 may be able to slow the growth of cancer cells and potentially even kill them.

In addition to its potential anti-cancer effects, CID-16020046 has also been studied for its potential use in the treatment of neurodegenerative diseases. These diseases, which include conditions like Alzheimer's disease and Parkinson's disease, are characterized by the loss of neurons in the brain. By inhibiting G9a and GLP, CID-16020046 may be able to protect these neurons and slow the progression of these diseases.

Research and Development

Research into the potential uses of CID-16020046 is ongoing. While the compound has shown promise in laboratory studies, further research is needed to determine its safety and efficacy in humans.

See Also

• G9a
• GLP
• Histone methylation
• Cancer
• Neurodegenerative disease

CID-16020046 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia